RFA-NS-27-015: BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

RFA-NS-27-015: BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

The National Institutes of Health is running a high-impact neuroscience infrastructure opportunity with a focus on scalable brain-mapping technologies: the BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS) Specialized Projects for Scalable Technologies NOFO (RFA-NS-27-015). In plain terms, this is a research funding stream for teams proposing technology and infrastructure innovations that make brain-wide connectivity maps faster, more precise, and more cost-effective.

This NOFO is a reissue of the previous RFA-NS-22-049 and is part of a 10-year BRAIN CONNECTS vision to build coordinated capabilities for multi-scale mapping of brain circuits in human, mouse, and non-human primate systems, with room for other species when scientifically justified. It is specifically a U01 cooperative agreement, and the title flags clinical trials are not allowed.

The immediate application round is due 9 July 2026 at 5:00 PM local time of the applicant organization, with additional published NIH application windows in early 2027 and late 2027. The NOFO also has an expiration date of 5 October 2027.

Key details at a glance

What this opportunity is actually funding

This opportunity is not a simple one-project science grant. It funds technical development and scaling work inside the neuroscience ecosystem.

From the NOFO text, funded projects are expected to address any part of the connectivity pipeline where technical limits are currently bottlenecking progress:

• tissue processing
• data collection
• image acquisition, alignment, and registration
• segmentation and annotation
• error correction
• integration into broader neuroscience environments
• large-scale interpretation and dissemination of connectivity outputs

The explicit goal is to develop and validate current or emerging technologies capable of generating comprehensive brain connectivity atlases. The program is intentionally practical in orientation: tools should lead toward faster and more reliable extraction of whole-brain wiring diagrams.

The NOFO also emphasizes that funded projects should integrate with the larger BRAIN CONNECTS Network, so a strong fit is stronger when proposals are designed to contribute reusable infrastructure, interoperable outputs, and standards-aligned approaches rather than isolated one-off methods.

The strategic role of this NOFO is to move from experimental, isolated technical methods toward scalable systems with throughput and generalizability. Projects that combine method innovation with engineering discipline, and that can generalize across scales and potentially across species, align best with review expectations.

Who this is most suitable for

This NOFO is most relevant if you represent a team with at least one of the following profiles:

• core neuroscience labs building data-rich, high-throughput analysis infrastructure;
• engineering groups proposing image, signal, or connectomics workflow automation;
• multi-site teams that can bridge biology, computation, and data standards;
• centers, consortia, or partnerships that already contribute to neuroscience community resources.

In practical terms, this is often a stronger fit for teams that can do both:

1. Technical depth (engineering, algorithms, experimental validation)
2. Translation to community-ready pipelines and outputs.

Because this is a U01 cooperative agreement, teams should also be comfortable with periodic scientific coordination with NIH staff and other network projects. This is a partnership model, not a stand-alone microgrant.

Institutional and applicant expectations

The NOFO’s Section I identifies a consortium of participating NIH components (NINDS, NEI, NIA, NIAAA, NIBIB, NICHD, NIDCD, NIDA, NIMH, NCCIH), which is normal for BRAIN Initiative announcements. It is not an institution-specific program.

Key practical expectations pulled directly from the NOFO:

• The mechanism is U01 Cooperative Agreement. That means NIH may retain substantial scientific/programmatic involvement.
• The application window supports new applications and references renewal/resubmission/revision where allowed.
• Paper submissions are not accepted.
• Registration and credentials are hard gates: PD/PI must include a valid eRA Commons ID.
• The unique entity identifier used on the application should match what is used in eRA Commons and SAM.

If your institution has not already completed SAM/UEI/eRA/Grants.gov setup, that is the top risk in this NOFO. Deadlines are fixed and compliance checks are strict in NIH systems, so teams that delay registration often get excluded before science review.

Funding level and award mechanics in context

Unlike some NOFOs that publish a single expected per-award amount, this document gives the program-level signal most useful at the planning stage:

• Estimated total: $10M in the first year
• Expected range of awards: about 3–6

This suggests a competitive environment with substantial but concentrated funding. For applicants, that means two things:

• You should optimize for clarity and feasibility, not an oversized budget
• Strong technical specificity matters more than broad ambition.

Because no fixed award size is provided in the captured section, budget justification must still be tightly tied to milestones, compute capacity, personnel, validation datasets, and dissemination pathways. A proposal that overpromises infrastructure complexity or broad scope without a clear staged build can be scored as weak on feasibility.

Timeline and critical dates

The NOFO provides an explicit multi-date schedule, which is important when planning with collaborators, core facilities, and institutional offices:

• Posted: 28 May 2026
• Earliest submission date: 09 June 2026
• NIH review cycle 1 due date: 09 July 2026
• NIH review cycle 2 due date: 08 February 2027
• NIH review cycle 3 due date: 04 October 2027
• Expiration: 05 October 2027

The official statement says all applications are due by 5:00 PM local time of the applicant organization, and NIH recommends early submission to allow correction time.

The NOFO also links each due date to peer review, advisory council review, and earliest start date blocks, which you should treat as planning anchors. A technically excellent application submitted too close to deadline may still fail operationally if internal validation, pre-award checks, and compliance steps cannot complete.

A practical timeline for teams

If you are targeting the first cycle, a practical timeline looks like this:

• Week 1–2: Confirm fit against scope; decide whether the proposal truly addresses scalable connectivity pipeline needs.
• Week 3–5: Draft scientific/technical aims and define dataset strategies.
• Week 6–8: Build registration hygiene (eRA Commons role assignments, SAM/UEI, Grants.gov package path).
• Week 9–10: Draft resource-sharing and dissemination sections.
• Week 11–12: Complete budget and compliance attachments; request internal review.
• At least 48 hours before deadline: run final formatting, validation, and pre-submit checks through ASSIST or Grants.gov Workspace.

This is not rigid, but helps avoid avoidable process issues.

Application process and registration requirements

The NOFO states that paper submissions are not accepted. Applications are submitted electronically using standard NIH routes referenced under “How to Apply,” typically ASSIST or Grants.gov Workspace depending on your institution’s setup.

Before submission, confirm all of the following:

• Organizational registration completed;
• eRA Commons profile for each applicant institution up to date;
• Correct PD/PI credentials entered;
• Unique entity identifier matches SAM/eRA records;
• Required sections prepared for all relevant review domains (methods, rigor, inclusion, animal/human-subject sections where applicable);
• Institutional approvals and signatures configured according to your internal workflows.

The NOFO also notes post-submission materials procedures. In particular, one-page updates with preliminary data are allowed as post-submission materials, with strict timing aligned to 30 days before study section meeting.

The lesson for applicants is straightforward: treat registration and compliance with the same importance as scientific writing. NIH NOFOs often fail at submission gates long before peer-review scoring starts.

How NIH reviews these applications

NIH explicitly applies peer review criteria, and this NOFO reinforces two practical points:

• Projects should clearly improve speed, cost-effectiveness, precision, and interpretability of brain-wide connectivity mapping;
• Technical approaches that are both novel and scalable are preferred over incremental or narrow technical variants.

Reviewers are asked to assess:

• Significance and relevance to the BRAIN CONNECTS goals;
• Innovation and technical rigor in developing scalable technology;
• Feasibility and quality of data and analysis pipeline;
• Integration potential into broader neuroscience environments;
• For human or vertebrate animal work, the usual protections and relevance criteria.

The NOFO also ties project success to network integration. Awards are expected to contribute to coordinated BRAIN CONNECTS outputs rather than isolated tools with limited field reuse.

What reviewers reward

Submissions often perform better when they:

• define clearly the bottleneck they solve;
• show measurable outputs and validation milestones;
• explain how new tools will be adopted outside the proposing team;
• include realistic resource plans matched to timeline and sample throughput;
• keep the scope focused on the connectivity objective without adding unrelated side projects.

What often hurts a proposal

• Proposals that only describe broad platform dreams without a first version you can realistically deliver;
• weak links between technical design and neuroscience interpretation;
• unclear roles for dataset generation, annotation, and validation;
• registration/compliance gaps (these usually stop applications at intake);
• claiming clinical work where title/category indicates clinical trials are not allowed.

Strategic preparation checklist

A strong NIH technology NOFO application usually includes both scientific and operational rigor.

1) Scope and technical design

Your Specific Aims should map directly to one or more parts of the connectivity pipeline (for example: alignment, annotation, error correction, integration). Include explicit output metrics and explain how success is measured.

A common mistake is submitting “fancy engineering” with no neuroscience translation plan. Make sure you can explain who uses the output and how it changes interpretation of connectivity.

2) Collaboration and interoperability

Because BRAIN CONNECTS emphasizes networked integration, add explicit plans for interoperability:

• metadata standards,
• file and annotation formats,
• reproducibility checks,
• compatibility with shared analysis environments.

A technically strong but isolated tool may be scored lower than one that plugs into community workflows.

3) Compliance planning from day one

Start your checklist in parallel with proposal writing:

• confirm all eRA and NIH registrations;
• assign institutional owner for grants submission;
• line up review of any animal or human-subject sections even if they are not central;
• align proposal narrative to requested mechanism (cooperative agreement style).

In U01 contexts, teams should explicitly consider post-award coordination points and governance expectations.

4) Budget realism

Tie every budget line to a named milestone. Reviewers and program staff are less interested in abstract budget scale and more in whether the allocated costs produce verifiable outputs and allow scaling across rounds.

5) Dissemination design

Include a practical dissemination path that supports the BRAIN community, for example:

• code and workflow release plans,
• benchmark datasets,
• documentation quality,
• validation reports and limitations sections,
• publication or resource-sharing strategy.

FAQ

Is this a fellowship, internship, or training program?

No. This is a research cooperative agreement (U01) focused on scalable connectomics technology.

Does it fund clinical trials?

No. The announcement title and terms indicate clinical trials are not allowed.

Is foreign participation possible?

The NOFO identifies broad NIH involvement but does not establish a blanket ban for foreign organizations in the captured sections. Confirm final institutional eligibility and participation rules in Section III of the full announcement before formal application planning.

Are post-submission materials allowed?

Yes. The NOFO references accepted post-submission materials and specifically allows a one-page update with preliminary data, with a standard NIH timing window.

Which due date should I use?

For the 2026 application cycle, the upcoming due date in the captured schedule is 9 July 2026. There are additional cycles in 2027, and the NOFO expires in 2027.

Official links and next steps

1. Review the full NOFO announcement text for the complete Section III eligibility and policy details.
2. Verify all institution registrations and PI credentials before writing the final package.
3. Finalize a concrete one-page technical scope statement and data-sharing strategy.
4. Submit early to allow for error correction.

Useful links

• Official NOFO copy: https://files.simpler.grants.gov/opportunities/6219f5d0-0978-4477-8a3f-13d2c43d8c55/attachments/8e3130b7-f23c-48e5-bc2e-07eeb38bee2e/RFA-NS-27-015-Full-Announcement.html
• NIH Grant and funding pathways: https://www.grants.nih.gov/funding
• NIH funding opportunities context (Grants.gov is the single official portal): https://www.grants.nih.gov/funding/explore-nih-opportunities

Monitoring and practical caution

Because this is a federal multi-annual round with several application deadlines, treat each published cycle as fresh competition. Teams should keep a short internal monitoring cadence:

• confirm status shortly before each deadline,
• verify package guidance and any Notices of Policy Changes,
• check for administrative updates from participating institutes,
• maintain contact points for the NOFO’s scientific and peer-review support.

The most reliable strategy is not a broad promise to “do brain mapping,” but a specific, reviewable promise to deliver measurable technology outputs that move NIH’s BRAIN CONNECTS roadmap forward.